Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $16.6900 (-2.8%) ($16.6900 - $16.6900) on Tue. Feb. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.05% (three month average) | RSI | 30 | Latest Price | $16.6900(-2.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -6% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.525% in a week (0% probabilities). VIXM(-35%) VXX(-27%) IGOV(-15%) UNG(-11%) UUP(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.525% (StdDev 3.05%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $7.85(-52.97%) | Resistance Level | $18.83 | 5 Day Moving Average | $17.56(-4.95%) | 10 Day Moving Average | $18.31(-8.85%) | 20 Day Moving Average | $18.83(-11.36%) | To recent high | -36.6% | To recent low | 0% | Market Cap | $1.24b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |